Oral Cancer Treatment Market Report by Type (Oral Squamous Cell Carcinoma, Oral Verrucous Carcinoma, Mucoepidermoid Carcinoma, Oral Cavity Lymphomas), Treatment Type (Chemotherapy, Radiation Therapy, Targeted Therapy, Surgery, and Others), Age Group (30-49, 50-69, Above 70), End-User (Hospital, Home Care, Specialty Clinics, and Others), and Region 2024-2032

Oral Cancer Treatment Market Report by Type (Oral Squamous Cell Carcinoma, Oral Verrucous Carcinoma, Mucoepidermoid Carcinoma, Oral Cavity Lymphomas), Treatment Type (Chemotherapy, Radiation Therapy, Targeted Therapy, Surgery, and Others), Age Group (30-49, 50-69, Above 70), End-User (Hospital, Home Care, Specialty Clinics, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A7037
Buy Now

Oral Cancer Treatment Market Size:

The global oral cancer treatment market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.06% during 2024-2032. The market is expanding rapidly driven by the increasing prevalence of oral cancer across the globe, rapid advancements in treatment technologies, heightened awareness about the disease and early detection initiatives, growing healthcare expenditure and insurance coverage, and the rising collaborative efforts in cancer research funding.

Report Attribute Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023
US$ 1.9 Billion
Market Forecast in 2032
US$ 3.0 Billion
Market Growth Rate (2024-2032)
5.06%

Oral Cancer Treatment Market Analysis:

  • Market Growth and Size: The market is witnessing stable growth, driven by the increasing incidence of oral cancer across the globe, rapid advancements in treatment technologies, and rising healthcare expenditure.
  • Major Market Drivers: Key drivers influencing the market growth include the rising prevalence of oral cancer, changing lifestyle factors like tobacco and alcohol use, rapid technological advancements in treatment methods, early detection initiatives, and growing healthcare expenditure and insurance coverage.
  • Key Market Trends: The key market trends involve the ongoing shift towards personalized medicine due to the rising prominence of targeted therapies and immunotherapies. Additionally, the rapid inclusion of radiation therapy and precision techniques in treatment strategies, is bolstering the market growth.
  • Geographical Trends: North America leads the market due to advanced healthcare systems and high investment in cancer research. Other regions are also showing significant growth, fueled by increasing awareness and improving healthcare infrastructure.
  • Competitive Landscape: The market is characterized by the active involvement of key players that are engaged in research and development (R&D), collaborations, and expanding their global presence. Furthermore, companies are focusing on mergers, acquisitions, and partnerships for market expansion and innovation.
  • Challenges and Opportunities: The market faces various challenges, such as disparities in healthcare access across the globe and the high cost of advanced treatments. However, the ongoing research for new treatment modalities, and the potential for early detection and screening programs, are creating new opportunities for the market growth.
     

Global Oral Cancer Treatment Market

Oral Cancer Treatment Market Trends:

Increasing prevalence of oral cancer

The rising incidence of oral cancer across the globe, driving the need for effective oral cancer treatment, is one of the major factors boosting the market growth. In line with this, the increasing number of oral cancer cases attributed to various risk factors, including tobacco use, alcohol consumption, human papillomavirus (HPV) infection, and exposure to sunlight, is acting as a growth-inducing factor. In addition to this, the increasing investment in research and development (R&D) by pharmaceutical companies to innovate more effective and less toxic treatments is stimulating the market growth. Additionally, the rising focus by governments and health organizations across the globe on oral cancer screening and early detection programs is anticipated to drive the market growth. 

Rapid advancements in cancer treatment technologies

The rapid technological advancements in cancer treatment methods, such as targeted therapy, immunotherapy, and personalized medicine are major factors propelling the market growth. Targeted therapies are designed to specifically attack cancer cells without damaging normal cells, leading to better treatment outcomes and fewer side effects. Moreover, immunotherapy empowers the body's immune system to fight cancer cells more effectively. Along with this, the introduction of personalized medicine that tailor treatment to individual patients based on their genetic makeup, facilitating effective and efficient treatment regimens, is bolstering the market growth. These technological advancements make treatments more precise and minimally invasive (MI) while increasing patient survival rates.

Growing awareness and early detection initiatives

The increasing awareness about oral cancer and its symptoms, coupled with rising initiatives for early detection, is catalyzing the market growth. Moreover, the widespread organization of public health campaigns and educational programs that help in increasing awareness about the risk factors, symptoms, and the importance of early detection of oral cancer, is acting as a growth-inducing factor. In addition to this, the rising advancements that lead to the early detection and improve the success and survival rate of the treatment are fostering the market growth. In line with this, the growing awareness among consumers, encouraging them to seek medical advice for symptoms, thereby leading to an increase in the diagnosis and treatment of oral cancer, is favoring the market growth.

Increasing healthcare expenditure and insurance coverage

The rising healthcare expenditure, leading to the availability and accessibility of cancer treatment facilities, advanced equipment, and skilled healthcare professionals, is creating a positive outlook for the market growth. In line with this, the increasing investment in healthcare facilities, which enhances the overall quality and availability of cancer treatment, making it accessible to a larger portion of the population, is fueling the market growth. Additionally, the growing prevalence of expanded insurance coverage that makes cancer treatment more affordable is positively impacting the market growth. Besides this, the introduction of insurance policies that cover a wide range of cancer treatments, including surgeries, chemotherapy, radiation therapy, and newer treatments like immunotherapy, while reducing the financial burden on patients and encouraging them to seek timely and effective treatment, is anticipated to drive the market growth. 

Heightened collaboration and funding for cancer research

The escalating collaborative efforts among research institutions, pharmaceutical companies, and healthcare providers, leading to significant advancements in understanding and treatment of oral cancer, is a major factor contributing to the market growth. In addition to this, the increasing funding from government agencies, non-profit organizations (NGOs), and private entities for ongoing research and development (R&D) in cancer treatment is catalyzing the market growth. Besides this, the burgeoning reliance on funding to support a wide range of activities, including basic research, understanding cancer biology, clinical trials, new treatment tests, and the development of innovative technologies, is offering remunerative growth opportunities for the market.

Oral Cancer Treatment Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, treatment type, age group, and end-user.

Breakup by Type:

  • Oral Squamous Cell Carcinoma
  • Oral Verrucous Carcinoma
  • Mucoepidermoid Carcinoma
  • Oral Cavity Lymphomas
     

Oral squamous cell carcinoma accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes oral squamous cell carcinoma, oral verrucous carcinoma, mucoepidermoid carcinoma, and oral cavity lymphomas. According to the report, oral squamous cell carcinoma represented the largest segment.

Oral squamous cell carcinoma (OSCC) represents the largest segment owing to its heightened occurrence among individuals across the globe. It is present in the squamous cells lining the oral cavity. OSCC is strongly associated with tobacco use, alcohol consumption, and HPV infection. Additionally, the increasing research and innovation efforts in OSCC, leading to the availability of various treatment options, such as surgery, radiation therapy, chemotherapy, and targeted therapy, are boosting the market growth. Besides this, the growing awareness about risk factors and the heightened push for early detection and screening programs are enhancing the market growth.

Oral verrucous carcinoma is a rare type of oral cancer characterized by slow-growing, locally invasive tumors. The rising focus on surgical treatments and the development of targeted therapies that effectively manage this unique type of cancer is fostering the market growth. Along with this, the increasing research into the molecular and genetic underpinnings of oral verrucous carcinoma, leading to personalized and effective treatment options, is favoring the market growth.

Mucoepidermoid carcinoma occurs in the salivary glands, known for its heterogeneous nature, ranging from low-grade, slow-growing tumors to high-grade, aggressive forms. The treatment involves surgery combined with radiation or chemotherapy in more aggressive cases. Moreover, rapid advancements in surgical techniques and the ongoing development of targeted therapies and novel chemotherapeutic agents are boosting the market growth.

Oral cavity lymphomas occur on the lymphatic system presented in the oral cavity. The treatment includes chemotherapy, radiation therapy, and, in some cases, targeted biological therapies. Moreover, the development of new chemotherapeutic and immunomodulatory agents, as well as advancements in radiation therapy techniques, are fostering the market growth.

Breakup by Treatment Type:

  • Chemotherapy
  • Radiation Therapy
  • Targeted Therapy
  • Surgery
  • Others
     

Radiation therapy holds the largest share in the industry

A detailed breakup and analysis of the market based on the treatment type has also been provided in the report. This includes chemotherapy, radiation therapy, targeted therapy, surgery, and others. According to the report, radiation therapy accounted for the largest market share.

Radiation therapy represents the largest segment due to its efficacy in treating various stages of oral cancer. Moreover, the rising adoption of radiation therapy owing to its ability to target cancerous cells while preserving surrounding healthy tissue, is supporting the market growth. Additionally, the development of advanced techniques like intensity-modulated radiation therapy (IMRT) and brachytherapy, which enhances the precision and effectiveness of radiation therapy, is acting as a growth-inducing factor. Besides this, the heightened awareness about the versatility of the therapy as a standalone treatment or in combination with other modalities, such as surgery and chemotherapy is fueling the market growth.

Chemotherapy is utilized with other treatment modalities and involves the application of drugs to destroy cancer cells. It is utilized in cases where the cancer has metastasized or as a neoadjuvant or adjuvant therapy. Moreover, the continuous development of new chemotherapeutic agents and drug combinations to increase efficacy and reduce toxicity is strengthening the market growth. 

Targeted therapy offers a more personalized approach to cancer treatment. It focuses on specific molecular targets associated with cancer growth and spread. Moreover, the rising popularity of targeted therapy due to its higher efficacy and lower side effects compared to traditional chemotherapy is enhancing the market growth. Additionally, the development of targeted drugs that can inhibit specific pathways or proteins involved in oral cancer progression is driving the market growth.

Surgery is known as the first line of treatment for many types of oral cancers, particularly those detected at an early stage. Surgical interventions include minor procedures, removal of small tumors, and more extensive surgeries involving the removal of larger areas of the mouth or throat. The increasing demand for surgeries driven by rapid advancements in techniques and technologies, including minimally invasive (MI) procedures and robotic surgery, is fueling the market growth.

Breakup by Age Group:

  • 30-49
  • 50-69
  • Above 70
     

50-69 represents the leading market segment 

The report has provided a detailed breakup and analysis of the market based on the age group. This includes 30-49, 50-69, and above 70. According to the report, 50-69 represented the largest segment.

The 50-69 age group constitutes the largest segment in the market, attributed to prolonged exposure to risk factors, like tobacco and alcohol use, as well as the accumulation of genetic mutations over time. Moreover, the increasing availability of treatment options for individuals in this demographic, including surgery, radiation therapy, chemotherapy, and targeted therapy, is fostering the market growth. Along with this, the rising investment in research for new treatment methods and technologies, coupled with heightened patient education and adoption of preventive measures, is boosting the market growth. Besides this, the growing emphasis on effective treatment, combined with quality-of-life considerations, is stimulating the market growth.

The 30-49 age group represents a smaller segment, as oral cancer in this demographic is less common. However, they are associated with specific risk factors, such as HPV infection and lifestyle choices. Moreover, rapid advances in early detection and treatment, as younger patients have better overall health, are propelling the market growth. 

Individuals above the age of 70 represent a smaller section, and the treatment approach is influenced by the patient's overall health and the presence of comorbidities. The choice of treatment is more conservative, prioritizing the quality of life and managing side effects, with a focus on less invasive treatments.

Breakup by End-User:

  • Hospital
  • Home Care
  • Specialty Clinics
  • Others
     

Hospital exhibits a clear dominance in the market 

A detailed breakup and analysis of the market based on the end-user has also been provided in the report. This includes hospital, home care, specialty clinics, and others. According to the report, hospital accounted for the largest market share.

Hospitals represent the largest share, attributed to their comprehensive care, encompassing diagnosis, treatment, and post-treatment follow-up. Hospitals are equipped with advanced technologies and a team of specialized professionals, making them well-suited for managing complex oral cancer cases that require multidisciplinary approaches. Moreover, the increasing availability of services like surgery, radiation therapy, chemotherapy, and supportive care for patients are bolstering the market growth. Besides this, the presence of specialized oncology departments in hospitals and their capability to offer a wide range of treatments is contributing to the market growth. 

Specialty clinics focus on specific treatment modalities, such as radiation therapy or chemotherapy. They offer a personalized approach and provide quicker access to care compared to hospitals. Moreover, the rising popularity of specialty clinics among patients seeking specialized treatments or second opinions is propelling the market growth.

Home care treatment plans cater to patients who require ongoing care without hospitalization, such as those in recovery or with advanced-stage cancer. Home care services provide nursing care, pain management, nutritional support, and psychological counseling. The increasing preference for at-home care among patients, which can provide comfort and reduce hospital-related expenses, is fostering the market growth.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

North America leads the market, accounting for the largest oral cancer treatment market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America represents the largest market share due to advanced healthcare infrastructure and the presence of leading pharmaceutical and biotechnology companies that are engaged in cancer research. Moreover, the growing prevalence of oral cancer due to lifestyle factors like tobacco and alcohol use is boosting the market growth. Additionally, the strong focus on cancer research to develop new treatment modalities, including targeted therapies and immunotherapies, is acting as a growth-inducing factor. Along with this, the well-established healthcare policies and reimbursement frameworks, which facilitate access to cancer treatment, are contributing to the market growth.

Europe’s oral cancer treatment market is characterized by advanced healthcare systems and robust cancer research initiatives. Moreover, the rising standards of healthcare, with considerable investments in cancer research and treatment, are boosting the market growth. Besides this, the increasing awareness about oral cancer, growing government support for healthcare, and the adoption of modern treatment techniques are strengthening the market growth.

The Asia Pacific region is growing exponentially, due to its large population base and increasing prevalence of oral cancer. Moreover, improving healthcare infrastructure, rising healthcare spending, and growing awareness of oral cancer are strengthening the market growth. Besides this, the development and adoption of new treatment modalities due to the rising incidence of oral cancer linked to factors, such as tobacco consumption and dietary habits are favoring the market growth. 

Latin America’s market is influenced by the gradual improvement in healthcare infrastructure and increasing access to healthcare services in various countries. Moreover, the growing public awareness about oral cancer and its risk factors, as well as the introduction of modern treatment methods, is anticipated to drive the market growth. 

The Middle East and Africa (MEA) region is showing potential for growth in the market, driven by factors, such as escalating healthcare investments, rising focus on healthcare reforms, and the establishment of specialized cancer treatment centers. Besides this, the heightened focus on efforts to improve healthcare infrastructure and increase public awareness about oral cancer are driving the market growth.

Leading Key Players in the Oral Cancer Treatment Industry:

Major players are engaged in various strategic initiatives to strengthen their positions. They are investing in research and innovation activities to discover novel therapeutics and refine existing treatments to enhance efficacy and reduce side effects. Moreover, many companies are focusing on the development of targeted therapies and immunotherapies, representing a new frontier in oral cancer treatment. Besides this, they are forming collaborations and partnerships to combine expertise, share resources, and accelerate the development of new treatments. Additionally, the leading firms are also focusing on mergers to expand their portfolios and enter new markets.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Bristol-Myers Squibb Company
  • Merck & Co. Inc.
     

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

  • In December 2023, Bristol Myers Squibb announced that it will showcase data demonstrating improved outcomes in earlier stages of oral cancer, durable long-term benefits with OPDIVO-based regimens.
  • In January 2024, Merck & Co. Inc. announced that Gebasaxturev is under clinical development and is currently in Phase II for Oral Cavity (Mouth) Cancer.

Oral Cancer Treatment Market Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Scope of the Report Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
  • Type
  • Treatment Type
  • Age Group
  • End-User
  • Region
Types Covered Oral Squamous Cell Carcinoma, Oral Verrucous Carcinoma, Mucoepidermoid Carcinoma, Oral Cavity Lymphomas
Treatment Types Covered Chemotherapy, Radiation Therapy, Targeted Therapy, Surgery, Others
Age Groups Covered 30-49, 50-69, Above 70
End-Users Covered Hospital, Home Care, Specialty Clinics, Others
Regions Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Bristol-Myers Squibb Company, Merck & Co. Inc., etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the oral cancer treatment market from 2018-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the global oral cancer treatment market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the oral cancer treatment industry and its attractiveness.
  • The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.

Key Questions Answered in This Report

The global oral cancer treatment market was valued at US$ 1.9 Billion in 2023.

We expect the global oral cancer treatment market to exhibit a CAGR of 5.06% during 2024-2032.

The rising occurrence of oral cancer, owing to excessive smoking of cigars, cigarettes, and pipes and chewing of tobacco, along with the growing awareness regarding the early detection and treatment of oral cancer, is primarily driving the global oral cancer treatment market.

The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective oral cancer treatment procedures to reduce the risk of the coronavirus infection upon hospital visits and interaction with healthcare professionals or medical equipment.

Based on the type, the global oral cancer treatment market has been segmented into oral squamous cell carcinoma, oral verrucous carcinoma, mucoepidermoid carcinoma, and oral cavity lymphomas. Among these, oral squamous cell carcinoma currently exhibits a clear dominance in the market.

Based on the treatment type, the global oral cancer treatment market can be divided into chemotherapy, radiation therapy, targeted therapy, surgery, and others. Currently, radiation therapy accounts for the majority of the global market share.

Based on the age group, the global oral cancer treatment market has been categorized into 30-49, 50-69, and above 70, where 50-69 currently holds the largest market share.

Based on the end user, the global oral cancer treatment market can be segregated into hospital, home care, specialty clinics, and others. Currently, hospital exhibits a clear dominance in the market.

On a regional level, the market has been classified into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global oral cancer treatment market include Bristol-Myers Squibb Company, Merck & Co. Inc., etc.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Oral Cancer Treatment Market Report by Type (Oral Squamous Cell Carcinoma, Oral Verrucous Carcinoma, Mucoepidermoid Carcinoma, Oral Cavity Lymphomas), Treatment Type (Chemotherapy, Radiation Therapy, Targeted Therapy, Surgery, and Others), Age Group (30-49, 50-69, Above 70), End-User (Hospital, Home Care, Specialty Clinics, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More